Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001330814 | SCV001522631 | uncertain significance | Spastic ataxia 4 | 2019-03-27 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV002546416 | SCV002944005 | uncertain significance | not provided | 2022-06-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1029511). This variant has not been reported in the literature in individuals affected with MTPAP-related conditions. This variant is present in population databases (rs771770775, gnomAD 0.01%). This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 281 of the MTPAP protein (p.Thr281Ser). |
Prevention |
RCV003405558 | SCV004116427 | uncertain significance | MTPAP-related disorder | 2023-06-27 | criteria provided, single submitter | clinical testing | The MTPAP c.842C>G variant is predicted to result in the amino acid substitution p.Thr281Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-30615503-G-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |